UPDATE: Deutsche Bank Downgrades Mead Johnson Nutrition Given Current Valuation

In a report published Monday, Deutsche Bank analyst Eric Katzman downgraded the rating on Mead Johnson Nutrition (NYSE: MJN) from Buy to Hold, but reiterated the $103.00 price target.

In the report, Deutsche Bank noted, “With recent headlines pointing to Danone's interest in Mead Johnson as a potential M&A target (Reuters, 10/17/14) and the latter's stock now up close to 20% for 2014, we believe the time is right to downgrade the shares. Given current valuation (25x P/E, 17x EBITDA), we adjust our fundamental-based opinion on Mead to HOLD from BUY, maintaining our $103 target, and removing the stock as our 2014 ‘Top Pick'.”

Mead Johnson Nutrition closed on Friday at $100.23.